Personalized Management: Inoperable Gastrointestinal Stromal Tumors

Grants

Funding Acknowledgements

This author discloses the following: Dr Jayesh Desai is a consultant for Novartis, Pfizer, GSK, Bayer, Sanofi, Circadian, and Bionomics and receives research support from Novartis, GSK, and Roche. The remaining author discloses no conflicts.